Master'sOpen Access

Cardiac marker and heart disease risk in type 2 diabetes patients

2022
0 views
0 downloads
Advisor: Doç. Dr. Şevki Adem ; Dr. Samer Abdulhasan Muhı

Abstract (EN)

T2D has been related to poor lipid and lipoprotein metabolism and is a recognized risk factor for cardiovascular disease. NT-proBNP and soluble interleukin 1 receptor-like 1 indicators for myocardial strain and clinical risk factors in patients with type 2 diabetes are to be studied. Iraq's ALYARMOUK teaching hospital, National diabetes center and Specialized endocrinology and diabetes center provided 70 participants. Sixty people had type 2 diabetes and thirty were healthy. Each subject's blood was drawn, and serum samples were tested for NT-proBNP, sST2, and lipid profile using an ELISA Test Kit. HbA1c was also tested. Diabetes patients had 2041.12 114.65 NT-pro levels compared to control groups (793.01 156.91). Also, individuals with type 2 diabetes had higher sSt2 levels (10.79 0.73 vs. 5.01 0.74). Also, individuals with type 2 diabetes had higher HbA1c values (8.110.19) than healthy people (5.420.06). cholesterol, triglycerides, LDL, and HDL readings did not differ between patients and controls. While VLDL readings showed a greater difference between patients and controls.

Author

Ahmed Abdulsattar Alı Alı

How to Cite

Ahmed Abdulsattar Alı Alı (Master Thesis). Cardiac marker and heart disease risk in type 2 diabetes patients, 2022, Çankırı Karatekin Üniversitesi.

License

Tüm Hakları Saklıdır

This work is shared under the specified license terms.

More theses from Çankırı Karatekin Üniversitesi